Otsuka (OTCMKTS:OTSKY) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Otsuka (OTCMKTS:OTSKY) announced its quarterly earnings results on Friday. The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.05, Zacks reports. Otsuka had a net margin of 15.50% and a return on equity of 12.86%.

Otsuka Stock Down 2.4%

Shares of Otsuka stock traded down $0.95 on Friday, reaching $37.93. The stock had a trading volume of 27,515 shares, compared to its average volume of 41,434. The company has a quick ratio of 1.65, a current ratio of 2.21 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $40.74 billion, a P/E ratio of 15.23, a P/E/G ratio of 2.76 and a beta of 0.09. The company has a 50 day moving average price of $37.38 and a 200 day moving average price of $34.79. Otsuka has a 1 year low of $26.11 and a 1 year high of $40.92.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Otsuka from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. is a Japan-based healthcare company that manages a group of businesses focused primarily on pharmaceuticals, nutraceuticals, and consumer health products. Through its subsidiaries, the company researches, develops, manufactures, and markets prescription medicines, over-the-counter products, functional foods, and beverages.

Its pharmaceutical operations address areas including psychiatry, oncology, cardiovascular and renal diseases, and several other specialty conditions.